Literature DB >> 2505962

Drug-resistant tuberculosis.

M D Iseman1, L A Madsen.   

Abstract

Multiply resistant tuberculosis is on the rise throughout the world. It poses the risk that an increasing percentage of patients will have disease that cannot be cured in economically limited nations and, thus, resistant tubercle bacilli will be spread in an exponential manner. For such patients in the United States, aggressive chemotherapy, coupled with surgery in cases of localized disease, is the best hope for cure.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2505962

Source DB:  PubMed          Journal:  Clin Chest Med        ISSN: 0272-5231            Impact factor:   2.878


  16 in total

Review 1.  Drug-resistant tuberculosis.

Authors:  R Long
Journal:  CMAJ       Date:  2000-08-22       Impact factor: 8.262

2.  The multidrug-resistant tuberculosis challenge to public health efforts to control tuberculosis.

Authors:  M E Villarino; L J Geiter; P M Simone
Journal:  Public Health Rep       Date:  1992 Nov-Dec       Impact factor: 2.792

3.  Efficacy of Selected Respiratory Protective Equipment Challenged with Bacillus subtilis subsp. niger.

Authors:  B Johnson; D D Martin; I G Resnick
Journal:  Appl Environ Microbiol       Date:  1994-06       Impact factor: 4.792

Review 4.  Mycobacterium tuberculosis, autoimmunity, and vitamin D.

Authors:  Yinon Shapira; Nancy Agmon-Levin; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2010-04       Impact factor: 8.667

Review 5.  Molecular epidemiology of tuberculosis: current insights.

Authors:  Barun Mathema; Natalia E Kurepina; Pablo J Bifani; Barry N Kreiswirth
Journal:  Clin Microbiol Rev       Date:  2006-10       Impact factor: 26.132

Review 6.  MULTIDRUG RESISTANT TUBERCULOSIS - BIOMECHANISM, EPIDEMIOLOGY AND MANAGEMENT STRATEGIES.

Authors:  S C Tewari; S P Kalra; S Dangwal; R S Chatterji
Journal:  Med J Armed Forces India       Date:  2017-06-26

7.  CpG oligodeoxynucleotides enhance host defense during murine tuberculosis.

Authors:  Nicole P Juffermans; Jaklien C Leemans; Sandrine Florquin; Annelies Verbon; Arend H Kolk; Peter Speelman; Sander J H van Deventer; Tom van der Poll
Journal:  Infect Immun       Date:  2002-01       Impact factor: 3.441

Review 8.  Treatment and prevention of multidrug-resistant tuberculosis.

Authors:  I Bastian; R Colebunders
Journal:  Drugs       Date:  1999-10       Impact factor: 9.546

9.  Culture confirmed multidrug resistant tuberculosis: diagnostic delay, clinical features, and outcome.

Authors:  H S Schaaf; K Shean; P R Donald
Journal:  Arch Dis Child       Date:  2003-12       Impact factor: 3.791

10.  Antituberculous drug resistance in Manitoba from 1980 to 1989.

Authors:  R Long; J Manfreda; L Mendella; J Wolfe; S Parker; E Hershfield
Journal:  CMAJ       Date:  1993-05-01       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.